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Sickle cell anemia (SCA) is a severe disease characterized by a recessive autosomal inheritance. However, despite being a monogenic disease, SCA has clinical heterogeneity as different individuals with the same genotype have different clinical aspects. 1 Thus, the clinical diversity of SCA has been attributed to socioeconomic and environmental factors, and also to genetic modulators, which have been widely investigated in order to explain the heterogeneous pattern of the disease. 1 Regarding the classic genetic modulators associated with SCA, we can mention the beta (␤)-globin gene cluster haplotypes, alpha-thalassemia (␣-Thal), as well as epistatic genetic variations related to quantitative trait loci (QTLS) of several genes which act singly or interacting with each other, for instance the presence of a gene polymorphism in BCL11A and the olfactory receptor gene and its association with fetal hemoglobin (Hb F) concentration. [2] [3] [4] Genome-wide studies emphasize multigene interactions and the clinical profile of SCA patients. 5, 6 ␤-globin gene cluster haplotypes have been described and named according to the geographic region where they were first identified, and have also been correlated to differential Hb F levels, 7, 8 with some haplotypes (Bantu and Benin) associated with lower Hb F levels and less disease severity. 9, 10 Several studies related to ␤-globin gene cluster haplotypes have been performed and show differential distribution related to the studied group as these markers have been used as an anthropological tool, as well as their role in modulating laboratorial and clinical characteristics of SCA patients. 9 ␣-Thal is characterized by a deficiency or absence of ␣-globin chain synthesis and its combination with ␤ chain variants decreases the concentration of abnormal hemoglobin. [17] [18] [19] The reduced synthesis of the alpha globin chain results in changes in hematological parameters, decreasing the degree of hemolysis and cellular dehydration, and increasing the ratio between the volume and the cell membrane area of red blood cells in sickle cell patients. 17, 20 The coexistence of ␣-Thal with SCA has been associated to greater survival, and also with a reduction in the occurrence of chronic ulcers in the malleolar region. However, with the reduction of hemolysis and increase of hematocrit, there is an increase of blood viscosity; this is a risk for vaso-occlusion, and consequently, an increase in the frequency of painful crises and other clinical complications, such as retinopathies and bone necrosis. 21 Kato et al., in a review of reports related to sickle cell disease phenotypes, proposed that patients with the ␣-Thal trait have less hemolysis and endothelial alterations, but present a sub-phenotype associated to increases in blood viscosity and vaso-occlusion. 22 Therefore, the coexistence of ␤-globin gene cluster haplotypes and ␣-Thal has shown changes in the severity of the clinical profile of sickle cell disease patients (Table 1) .
Despite several studies describing the presence of these markers and their possible influences on the phenotype of SCA patients, changes described in a specific population are not necessarily found in others; this consolidates the concept that although the genetic event is unique and related to one http://dx.doi.org/10.1016/j.bjhh.2014.07.018 1516-8484/© 2014 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Editora Ltda. All rights reserved. Influence of ␤-globin gene haplotype, co-inherited ␣-Thal trait and Hb F on steady-state serum bilirubin levels in SCA
The ␤-globin haplotype and co-existing ␣-Thal trait did not have any significant influence on serum bilirubin levels Adekile et al. 28 The ␤-globin gene cluster haplotypes in SCA ␤-Globin gene haplotypes showed differences related only to Hb F levels and blood transfusion therapy, presence of ␣-Thal was associated to hematological alteration and spleen sequestration events Adorno et al. 29 Molecular characteristics of pediatric patients with SCA and stroke
Neonates with four or more alpha-genes, whose ␤-haplotype is Ben/CAR, atypical, or CAR/CAR seem to be at a higher risk for stroke Sarnaik et al. 30 Effect of microdeletions in the alpha globin gene and sickle cell glomerulopathy
Coinheritance of microdeletions in the alpha-globin gene locus in SCA patients confers "renoprotection"
Guasch et al. 31 Genotype-phenotype correlation of SCD in the United Arab Emirates
African haplotypes (Bantu and Benin) are related to a severe clinical presentation, and coinheritance of ␣-Thal trait in the African haplotypes had an ameliorating effect on hemolytic episodes, but vaso-occlusive crises were more frequent el-Kalla et al. 32 Effect of ␣-Thal on SCA linked to the Arab-Indian haplotype in India ␣-Thal is a powerful and additional epistatic factor on the Indian subcontinent Mukherjee et al. The Senegal DNA haplotype is associated with the amelioration of anemia in African-American SCA patients
The Senegal ␤-like globin gene cluster haplotype is associated with an amelioration of the hemolytic anemia that characterizes SCD Nagel et al. 40 point mutation in the ␤ globin gene (HBB), the clinical pattern of the disease involves multiple organs and systems, which affects the activation of a complex network of mechanisms and pathways not clearly understood. In this context, there is a high diversity of findings which are not yet globally consolidated about a common prognostic marker involving the SCA profile, except the genetic origin of the disease, the presence of hemoglobin S. In this issue of the Revista Brasileira de Hematologia e Hemoterapia, Camilo-Araújo present an analysis of the frequency of ␤S-globin haplotypes and alpha-thalassemia, and their influence on clinical manifestations and the hematological profile of children with sickle cell anemia. 41 
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